H-1B sponsorship profile: City Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, City Therapeutics, Inc filed 6 Labor Condition Applications covering 6 H-1B worker positions between fiscal year 2024 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (6 certified of 6 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on City Therapeutics, Inc’s H-1B petitions range from $115,000 at the low end to $155,000 at the high end, with a petition-weighted average of $129,917. That range reflects the mix of occupations the company sponsors, led by Principal Research Associate (2 petitions at $117,500 avg), followed by Senior Scientist and Senior Manager, CMC Quality Assurance. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. City Therapeutics, Inc is headquartered in Cambridge, MA under NAICS code 32541, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where City Therapeutics, Inc ranks. By H-1B petition volume, City Therapeutics, Inc is #23,486 of 119,880 employers nationally and #1,036 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.